Richard W. Fisher
Known title: DirectorCIK: 0001287510
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Tenet Healthcare Raises 2026 Outlook, Analysts Lift Targets. Tenet Healthcare recently raised its 2026 financial outlook, prompting analysts like Guggenheim to increase price targets to $307. This positive guidance has driven the stock higher, with the average analyst target now sitting at $285.32. While the company is trading near its 52-week high, questions remain about whether this recent strength is fully reflected in the current valuation.
Transaction History
| WBD | ▼ Sell | Other | 27,673 | $858K | 10/6/2026 | View on chart |
| WBD | ▼ Sell | Other | 16,106 | $500K | 10/6/2026 | View on chart |
| WBD | ▼ Sell | Open Market | 6,700 | $188K | 9/11/2026 | View on chart |
| WBD | ▼ Sell | Open Market | 20,000 | $549K | 8/12/2026 | View on chart |
| WBD | ▲ Buy | Grant | 9,067 | $0 | 6/9/2026 | View on chart |
| THC | ▲ Buy | Option Exercise | 1,333 | — | 5/22/2026 | View on chart |
| THC | ▼ Sell | Other | 493 | $86K | 5/22/2026 | View on chart |
| WBD | ▼ Sell | Open Market | 16,345 | $463K | 3/3/2026 | View on chart |
| THC | ▼ Sell | Open Market | 2,500 | $521K | 10/29/2025 | View on chart |
| THC | ▼ Sell | Open Market | 836 | $145K | 6/5/2025 | View on chart |
| WBD | ▲ Buy | Grant | 24,000 | $0 | 6/3/2025 | View on chart |
| THC | ▼ Sell | Open Market | 3,077 | $510K | 5/27/2025 | View on chart |
| THC | ▲ Buy | Option Exercise | 1,551 | — | 5/23/2025 | View on chart |
| THC | ▼ Sell | Other | 573 | $92K | 5/23/2025 | View on chart |
| THC | ▼ Sell | Open Market | 1,169 | $191K | 8/27/2024 | View on chart |
| THC | ▼ Sell | Open Market | 831 | $136K | 8/27/2024 | View on chart |
| THC | ▼ Sell | Open Market | 1,400 | $185K | 6/10/2024 | View on chart |
| WBD | ▲ Buy | Grant | 26,700 | $0 | 6/5/2024 | View on chart |
| THC | ▼ Sell | Open Market | 2,500 | $308K | 5/7/2024 | View on chart |
| THC | ▼ Sell | Open Market | 2,100 | $185K | 2/14/2024 | View on chart |
| THC | ▼ Sell | Open Market | 1,000 | $68K | 11/22/2023 | View on chart |
| THC | ▼ Sell | Open Market | 5,000 | $332K | 11/21/2023 | View on chart |
| THC | ▲ Buy | Grant | 2,846 | $0 | 5/26/2023 | View on chart |
| WBD | ▲ Buy | Grant | 16,345 | $0 | 5/9/2023 | View on chart |
| THC | ▼ Sell | Open Market | 9,817 | $431K | 12/6/2022 | View on chart |
| THC | ▼ Sell | Open Market | 7,439 | $468K | 7/25/2022 | View on chart |
| WBD | ▲ Buy | Grant | 16,106 | $0 | 6/29/2022 | View on chart |
| THC | ▲ Buy | Grant | 3,836 | $0 | 5/9/2022 | View on chart |
| WBD | ▲ Buy | Grant | 2,419 | $0 | 4/8/2022 | View on chart |
| THC | ▼ Sell | Open Market | 7,820 | $565K | 12/2/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
WBD faces political scrutiny of CNN and Skydance merger developments
A federal court order preventing the White House from banning CNN has been appealed by former President Trump, keeping the network's broadcast status under review. At the same time, Warner Bros. Discovery continues its merger process with Skydance, distributing warrants and issuing new debt as part of the exchange. Additionally, advertising on HBO Max and discovery+ in Italy has been paused following a decision by The Trade Desk.
WBD faces political scrutiny of CNN and Skydance merger developments. A federal court order preventing the White House from banning CNN has been appealed by former President Trump, keeping the network's broadcast status under review. At the same time, Warner Bros. Discovery continues its merger process with Skydance, distributing warrants and issuing new debt as part of the exchange. Additionally, advertising on HBO Max and discovery+ in Italy has been paused following a decision by The Trade Desk.